Resources

The latest in drug discovery, from novel targets and screening tools through to automation and computational chemistry

Target Based Discovery

University of Minnesota Awarded $6.5m for Male Contraceptive Discovery Effort

The grant could open the door to new oral contraceptive medication for men and prevent unwanted pregnancy.
Target Based Discovery

Accelerating Target Discovery with Genomic and CRISPR Techniques

Benedict Cross, Chief Technology Officer at PhoreMost, leads our Discussion Group on Target-Based Drug Discovery using Genomic and CRISPR techniques.
Target Based Discovery

Accelerating Target Deconvolution for Therapeutic Antibody Candidates

Target deconvolution is crucial to the phenotypic discovery process. Jenny Mattsson of BioInvent International explains how using CRISPR/Cas9 screening is a more efficient target deconvolution approach.
Target Based Discovery

Expanding the Druggable Toolbox: Improving Access to Undruggable Targets

In this Commentary article, we explore the innovative approaches towards drug target identification being championed by Cambridge-based biotechnology company PhoreMost. Identifying new druggable targets may help to address a range of unmet diseases.
Target Based Discovery

Protein Linked to Increased Lung Cancer Survival

Evidence shows that targeting TLR2 with an agonist reduces lung tumour growth in mouse models.
Target Based Discovery

Bundle Cultrex™ BME with Select Proteins & Save

Use Promo Code: PROTBME15 to receive 15% off your order
Target Based Discovery

Using Innovative Approaches to Expand the Druggable Genome

Investigating the mysteries of proteins considered undruggable to expand the druggable genome.
Target Based Discovery

In Vitro Potency Assays for Immune Cell-Mediated Killing with the Maestro Z

Cell-based therapies are a rapidly growing area of research with great promise.
Target Based Discovery

Target Identification, Phenotypic and Cell-based Screening

Oxford Global’s discussion group brings together specialists in target identification, phenotypic, and cell-based screening
Target Based Discovery

Validation of an Impedance-based Cytotoxicity Assay for High Throughput Screening

High throughput screening requires careful validation of assay performance
Target Based Discovery

Axion: Cardiac Activity Assay

In vitro models are a proven powerful strategy for studying disorders of the human heart.
Target Based Discovery

Axion: Teer With Maestro Z

High-throughput assessment of barrier function.

Subscribe to Our Newsletter

Sign up for our monthly newsletter to
keep up with all things discovery